Research ArticleMetabolism, Transport, and Pharmacogenomics
Hepatobiliary Disposition of Atovaquone: A Case of Mechanistically Unusual Biliary Clearance
Mitesh Patel, Marta Johnson, Caroline J. Sychterz, Gareth J. Lewis, Cory Watson, Harma Ellens, Joseph W. Polli and Maciej J. Zamek-Gliszczynski
Journal of Pharmacology and Experimental Therapeutics July 2018, 366 (1) 37-45; DOI: https://doi.org/10.1124/jpet.117.247254
Mitesh Patel
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Marta Johnson
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Caroline J. Sychterz
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Gareth J. Lewis
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Cory Watson
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Harma Ellens
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Joseph W. Polli
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Maciej J. Zamek-Gliszczynski
Mechanistic Safety and Disposition (M.P., M.J., C.W., H.E., J.W.P., M.J.Z.-G.) and Bioanalysis, Immunogenicity, and Biomarkers (C.J.S.), GlaxoSmithKline, King of Prussia, Pennsylvania; and Mechanistic Safety and Disposition, GlaxoSmithKline, Ware, United Kingdom (G.J.L.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMetabolism, Transport, and Pharmacogenomics
Unusual Biliary Clearance of Atovaquone
Mitesh Patel, Marta Johnson, Caroline J. Sychterz, Gareth J. Lewis, Cory Watson, Harma Ellens, Joseph W. Polli and Maciej J. Zamek-Gliszczynski
Journal of Pharmacology and Experimental Therapeutics July 1, 2018, 366 (1) 37-45; DOI: https://doi.org/10.1124/jpet.117.247254
Research ArticleMetabolism, Transport, and Pharmacogenomics
Unusual Biliary Clearance of Atovaquone
Mitesh Patel, Marta Johnson, Caroline J. Sychterz, Gareth J. Lewis, Cory Watson, Harma Ellens, Joseph W. Polli and Maciej J. Zamek-Gliszczynski
Journal of Pharmacology and Experimental Therapeutics July 1, 2018, 366 (1) 37-45; DOI: https://doi.org/10.1124/jpet.117.247254
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement